Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Triglav Zdravje in Farmacija

+ Add to Watchlist

TRIZDFA:SV

23.34 EUR 0.46 1.93%

As of 08:52:00 ET on 03/25/2015.

Snapshot for Triglav Zdravje in Farmacija (TRIZDFA)

Year To Date: +18.84% 3-Month: +19.75% 3-Year: +28.21% 52-Week Range: 14.88 - 24.25
1-Month: +4.62% 1-Year: +49.81% 5-Year: - Beta vs SBITOP: 0.40

Mutual Fund Chart for TRIZDFA

No chart data available.
  • TRIZDFA:SV 23.34
  • 1M
  • 1Y
Interactive TRIZDFA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TRIZDFA

Triglav Zdravje in farmacija is a UCITS certified open-end fund incorporated in Slovenia. The Fund's objective is to achieve long-term capital growth. The Fund primarily invests in equitiy securities from global healthcare sector.

Inception Date: 10-03-2011 Telephone: Tel.: +386 1 300-73-00
Managers: GASPER DOVC
Web Site: www.triglavskladi.si

Fundamentals for TRIZDFA

NAV (on 2015-03-25) 23.34
Assets (M) (on 2015-03-25) 22.61
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for TRIZDFA

No dividends reported

Fees & Expenses for TRIZDFA

Front Load 4.00
Back Load 0.00
Current Mgmt Fee 2.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 2.76

Top Fund Holdings for TRIZDFA

Filing Date: 02/27/2015
Name Position Value % of Total
Johnson & Johnson 11,337 1,038,092 4.940%
iShares Global Healthcare ETF 9,969 949,833 4.520%
Novartis AG 10,445 928,819 4.420%
Gilead Sciences Inc 9,271 857,371 4.080%
Pfizer Inc 24,265 743,896 3.540%
Roche Holding AG 2,869 674,549 3.210%
Sanofi 6,829 598,899 2.850%
Novo Nordisk A/S 12,951 554,770 2.640%
UnitedHealth Group Inc 5,401 546,364 2.600%
Merck & Co Inc 10,330 535,857 2.550%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil